Date published: 2025-12-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

B7-1 Activators

B7-1 activators constitute a diverse array of chemical agents meticulously designed to modulate immune-related signaling pathways, orchestrating a complex cascade of events leading to the heightened expression of the B7-1 protein. These activators operate through indirect mechanisms, engaging with various receptors and signaling cascades that converge on pivotal transcription factors, ultimately enhancing the transcription of the B7-1 gene. Notably, molecules like lipopolysaccharide (LPS) trigger Toll-like receptor 4 (TLR4) and TLR9, activating NF-kB-a critical transcription factor known to enhance B7-1 expression, thereby revealing the intricate regulatory network governing this crucial costimulatory molecule. The activation of B7-1 holds profound implications for immune responses, with chemical activators assuming crucial roles in promoting antigen presentation and T-cell activation. Compounds such as phorbol 12-myristate 13-acetate (PMA) and imiquimod, by activating protein kinase C (PKC) and TLR7, respectively, induce signaling mechanisms that intricately lead to the upregulation of B7-1. This underscores the intimate interplay between intracellular signaling pathways and the modulation of the immune system, exemplifying how these chemical agents can selectively influence the expression of this pivotal costimulatory protein.

Furthermore, agents like interleukin-4 (IL-4) and granulocyte-macrophage colony-stimulating factor (GM-CSF) contribute to B7-1 gene expression by interacting with their specific receptors, engaging transcription factors STAT6 and STAT5. These pathways offer insights into indirect stimulation of B7-1 expression, highlighting the broader impact on immune system dynamics. Each chemical activator plays a distinct role in shaping the immune landscape, influencing the expression of B7-1 and, by extension, contributing to the finely tuned orchestration of immune responses. This intricate interplay between chemical activators and immune signaling pathways emphasizes the multifaceted nature of immune modulation and the pivotal role played by B7-1 in this complex regulatory network.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lipopolysaccharide, E. coli O55:B5

93572-42-0sc-221855
sc-221855A
sc-221855B
sc-221855C
10 mg
25 mg
100 mg
500 mg
$96.00
$166.00
$459.00
$1615.00
12
(2)

LPS activates Toll-like receptor 4 (TLR4) leading to the activation of NF-kB, which can upregulate B7-1 expression.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA activates protein kinase C (PKC) which can enhance the transcription factor AP-1, subsequently increasing B7-1 expression.

GM-CSF

83869-56-1sc-280759
5 µg
$516.00
1
(0)

GM-CSF receptor signaling can lead to STAT5 activation, which has been implicated in upregulating B7-1 expression.

Imiquimod

99011-02-6sc-200385
sc-200385A
100 mg
500 mg
$66.00
$278.00
6
(1)

As an agonist of TLR7, imiquimod can stimulate NF-kB activity, which might result in increased B7-1 expression.

Polyinosinic-polycytidylic acid potassium salt

31852-29-6sc-202767
5 mg
$194.00
(1)

This synthetic analog of double-stranded RNA activates TLR3, leading to NF-kB activation and potential upregulation of B7-1.